STOCKHOLDERS’ EQUITY |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | NOTE 5 – STOCKHOLDERS’ EQUITY
The Company’s authorized capital stock consists of 105,000,000 shares, comprised of shares of common stock, per share par value $, and shares of preferred stock, per share par value $.
Of the 5,000,000 shares of preferred stock authorized, the Board of Directors has designated the following:
Rights Under Preferred Stock
The Company’s classes of preferred stock include the following provisions:
Optional Conversion Rights of Preferred Stock
Issuance of Common Stock for Services
During the year ended December 31, 2025, the Company entered into several consulting agreements with unrelated entities for business development and general business consulting services (Consulting Agreements). The terms of the Consulting Agreements ranged from three to twelve months. Compensation under the Consulting Agreements consisted of cash payments as well as common stock shares and warrant issuances. Any cash paid in advance, along with the fair value of any common stock shares and warrants issued, is recorded as a prepaid asset and amortized through professional fees expense (for cash compensation) or stock-based compensation expense (for stock-based instruments issued).
During 2025, common stock shares issued under the Consulting Agreements totaled and warrant shares issued totaled . The fair value of the common shares issued totaled approximately $1,219,000 and the fair value of the warrants issued totaled approximately $191,000. The exercise price of the warrants was $1.00 per share and are exercisable over periods ranging from three to five years. Compensation expense recognized under these Consulting Agreements for the three and six months ended June 30, 2025, was approximately $274,000 and $502,000, respectively. Compensation recognized for the three and six months ended June 30, 2026, was approximately $60,000 and $197,000, respectively. unamortized compensation remains outstanding at June 30, 2026. A total of 380,000 warrant shares related to the Consulting Agreements remain outstanding at June 30, 2026, and December 31, 2025.
Effective January 23, 2026, the Company entered into a Business Development Agreement with a third-party consultant, with a service term of eleven months. Compensation under the agreement consisted of shares of the Company’s common stock issued and valued at the effective date of the agreement. The total fair value of the common stock issued was $133,500, based on a per share price of $0.89. The Company recognized approximately $36,000 and $61,000 in compensation expense for the three and six months ended June 30, 2026, respectively, associated with the amortization of the common stock fair value.
Effective May 1, 2026, the Company entered into a Consulting Agreement with a third-party consultant, with a service term of six months. Compensation under the agreement included an up-front cash payment of $20,000 and monthly cash payments during the term of the agreement. Upon the effective date of the Consulting Agreement, the Company also issued shares of the Company’s restricted common stock, fair valued at $92,400, and warrants for the purchase of 120,000 shares of common stock at an exercise price of $ per share, fair valued at $152,760 using the Black Scholes pricing model. For the three months ended June 30, 2026, the Company recognized approximately $ in stock-based compensation and $7,000 in professional fees expense under the agreement.
Issuance of Common Stock in Conjunction with Debt Issuances and Conversions
As discussed in Note 4, during the six months ended June 30, 2026, the Company issued a total of shares of its common stock, at a total value of $, resulting from conversion of outstanding debt principal. The Company also issued a total of shares of its common stock at a total value of $20,358 in conjunction with debt issuances during the six months ended June 30, 2026. Exemption from registration is claimed under Section 4(2). Section 3(a)(9) and Rule 506 of the Securities Act of 1933, as amended. No commissions were paid with respect to the aforementioned securities transactions.
2026 Issuances of Common Stock for Cash
During the six months ended June 30, 2026, the Company issued a total of shares of its common stock, at per share prices ranging from $0.50 to $1.03, for total net cash proceeds of approximately $2,541,000. During the three months ended June 30, 2026, the Company issued a total of shares of its common stock, at a total value resulting from cash payments of $1,412,500.
|